Asset 2 Conferences
Inflammation

Type 2 Immunity in Homeostasis and Disease (2nd edition)

12-13 December 2022, Ghent, Belgium
Organized in partnership with Cell Press
Followed by the satellite event ‘From basic science in Type 2 Immunity to the clinic’ on Dec 14
Campaign image - Type 2 Immunity in Homeostasis and Disease

Type 2 Immunity in Homeostasis and Disease (2nd edition)

Type 2 Immunity in Homeostasis and Disease (2nd edition)

Organized in partnership with Cell Press

Keep me postedAdd to calendar

Organized in partnership with Cell Press

Cell Press-Partner logo

After the Cell-VIB event on Type 2 Immunity organized in Bruges in December 2014, VIB launched the Type 2 Immunity in Homeostasis and Disease series in February 2019. Now, VIB is very pleased to organize the 2nd edition of that event. This conference will be organized in the Bijloke in Ghent, a 13th-century architectural marvel in the historic center of Ghent.

This conference will not only focus on new effector and regulatory mechanisms of the type 2 immune response. It will also offer a number of talks taking a broader look at type 2 immunity, dealing with such topics as type 2 immunity in homeostasis, growth and repair, metabolism, neuro-immune interactions, and cancer. Understanding these alternative roles for type 2 immunity will be essential to address the benefits and potential pitfalls of long-term inhibition of type 2 immunity by biologicals and could elucidate new therapeutic pathways for widespread diseases like asthma, obesity, diabetes, and cancer.

Satellite - 14 December
On Wednesday 14 December a satellite event ‘From basic science in Type 2 Immunity to the clinic’ will be held. During this satellite 8 international speakers will present their work in sessions focused on mucus plugging, eosinophils, and biologic interventions. The event is supported by Astrazeneca, GSK, and Sanofi.

Poster information
The format for your poster should be: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation. All accepted poster submissions will have a chance to win the Cell Press Poster Prize!

Share

Confirmed speakers

Federica Sallusto
Sallusto Federica -  Profile picture
Federica Sallusto

Federica Sallusto

Institute of Microbiology, ETH Zurich and Institute for Research in Biomedicine, Università della Svizzera Italiana, CH
Judi Allen
Allen Judi - profile picture
Judi Allen

Judi Allen

Lydia Becker Institute for Immunology & Inflammation, The University of Manchester, UK

Program

Day 1 - Monday, 12 December, 2022

08:00
08:35
Registration & coffee
08:35
08:45
Welcome
08:45
09:30
Keynote
08:45
09:30
Type 2 immunity and tissue resilience
09:30
12:45
Session 1: Type 2 Effector mechanisms
09:30
10:00
Cellular Mechanisms of Food Allergy
10:00
10:30
Cytokines in Type 2 Inflammation

Jamie Orengo

VP Research-Allergy & Immunity Regeneron Pharmaceuticals, US
10:30
11:00
Coffee break
11:00
11:30
Eosinophil subsets in intestinal inflammation
11:30
12:00
Neuro-immune axis in cancer: ILC-you in the bladder!

Camilla Jandus

University of Geneva & Ludwig Institute for Cancer Research Lausanne, CH
12:00
12:30
Protein crystals as drivers of Type 2 inflammation and mucus plugging
12:30
12:45
The aryl hydrocarbon receptor promotes intestinal tissue adapation of eosinophils
Selected from abstracts
12:45
13:30
Lunch
13:30
14:30
Poster session 1
14:30
16:45
Session 2: Type 2 Immunity in pathogen clearance
14:30
15:00
From Zebrafish to Humans: How Pathogenic Mycobacteria Reprogram the Host Immune Response
15:00
15:30
Perforin 2 controls unconventional cytokine release from mucosal APC
15:30
16:00
Matrix Regulation by Type 2 cytokines

Judi Allen

Lydia Becker Institute for Immunology & Inflammation, The University of Manchester, UK
16:00
16:15
Tissue remodeling by an opportunistic pathogen triggers allergic inflammation
16:15
16:45
Coffee break
16:45
18:00
Session 3: Type 2 Immunity-neuronal interactions
16:45
17:15
Non-redundant functions of group 2 innate lymphoid cells
17:45
18:00
Tuft cell-derived acetylcholine regulates epithelial fluid secretion during homeostasis and Type 2 immunity
Selected from abstracts
18:00
19:00
Reception
20:00
Conference dinner

Additional fee

Day 2 - Tuesday, 13 December, 2022

08:30
09:15
Registration & coffee
09:15
11:15
Session 4: Type 2 Immunity metabolism
09:15
09:45
Species-specific regulation of IL-33
09:45
10:15
Metabolic roles of Th2 cytokines

Chih-Hao Lee

Harvard University T.H. Chan School of Public Health, US
10:15
10:45
A Metabolic Perspective of Human ILC Differentiation
10:45
11:15
Coffee break
11:15
12:15
Session 5: Unsuspected roles of ILCs in Homeostasis
11:15
11:45
Function of ILC2 in bone marrow
11:45
12:15
Regulation of DC2 differentiation and function by dermal cytokines
12:15
13:15
Lunch
13:15
14:15
Poster session 2
14:15
16:30
Session 6: Type 2 Immunity Early Life
14:15
14:45
Stromal-immune interactions drive allergic immunity in the lung
14:45
15:15
Neonatal exposure to environmental triggers influences type 2 immunity to allergens
15:15
15:30
Co-existing Atoh1+ and Atoh1– progenitors contribute to tuft cell expansion during intestinal helminth infection
Selected from abstracts
15:30
16:00
Coffee break
16:00
16:30
The gut-lung axis: how early life perturbation of the microbiome influences Type 2 inflammation
16:30
17:25
Keynote
16:30
17:15
Human T lymphocytes: differentiation, migration and immune regulation

Federica Sallusto

Institute of Microbiology, ETH Zurich and Institute for Research in Biomedicine, Università della Svizzera Italiana, CH
17:15
17:25
Closing remarks

Day 3 - Wednesday, 14 December, 2022

Satellite: From basic science in Type 2 Immunity to the clinic

08:15
08:40
Registration & coffee
08:40
08:45
Welcome
08:45
11:15
Session 1: Mucus plugging
08:45
09:30
Clinical and molecular phenotypes of type 2 high forms of asthma

John Fahy

University of California San Francisco, UCSF, US
Keynote speaker
09:30
10:00
Mucus Plugging in Asthma – more than an obstruction to breathing
10:00
10:30
Epithelial Barrier Theory and Type 2 Immune Response
10:30
11:00
Coffee break
11:00
12:45
Session 2: Biologic interventions

Chair: John Fahy

11:00
11:30
Choosing Biologics Wisely for Severe Asthma: Complex Interplay between Eosinophils and Mucus
11:30
12:00
Is targeting the eosinophil sufficient in eosinophilic asthma?
12:00
12:45
Specific B cell responses in natural and induced B cell tolerance
Keynote speaker
12:45
14:15
Lunch & poster session
14:15
16:00
Session 3: Eosinophils
14:15
14:45
Targeting eosinophils in systemic eosinophilic conditions: achievements and challenges
14:45
15:15
Modeling human lung disease using iPSC derived airway epithelium
15:15
15:30
High-dimension flow cytometric screening resolves distinct stages of eosinophil development and Interleukin-5-driven transit amplification in eosinophilia
15:30
16:00
Airway Mucus: Production and Secretion of Glycopolymers in Health and Disease
16:00
16:10
Closing of the conference

Organizing committee

Abstracts

The full list of abstracts will be available on 28-11-2022 until 12-02-2023
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 28-11-2022 until 12-02-2023
This list will only be available for registered attendees of the event.